Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

62 results about "Mucous cell" patented technology

Method for promoting tissue regeneration on wound surfaces as device and treatment instrument or implant for carrying out method

For promoting tissue regeneration on wound surfaces (1) mechanical oscillation is coupled into the wound surfaces. A treatment instrument (2) coupled to an oscillation drive is brought into contact with the wound surface (1), or an implant is impinged with oscillation during and / or after being positioned in the tissue. The oscillation acts mechanically and thermally on the tissue in the region of the treated wound surface (1), and according to the intensity acts in a stimulating, traumatic, necrotic or cell-destroying manner. Therefore, biological elements inhibiting tissue regeneration are destroyed or denatured and the metabolism in the region of the wound surface is stimulated. The effect may also be a mechanical one, slightly compacting or regionally dislocating the tissue. Since the treatment can be effected during or after positioning an implant, necrosis in particular effects undesired cells, such as connective tissue cells, mucous cells and diseased cells having been brought to the wound surface with the implant, which cells may inhibit the intergrowth between tissue and implant.
Owner:WOODWELDING

Topical compositions for treatment of irritation of mucous membranes

A topical pharmaceutical or cosmetic composition for treatment of irritation of mucous cells such as mucosal cells of the eye, nose, and vagina is disclosed. The composition comprises an aqueous solution of at least one polyol selected from the group consisting of xylitol, myoinositol and mannitol and at least one substance selected from the group consisting of glycerol and urea. The composition contains less than 0.01% inorganic salt and is free of any oil-in-water or wax-in-water emulsion. In particularly preferred embodiments, the composition comprises an aqueous solution containing 1.5-5% (w / v) xylitol and 0.9-2.0% (w / v) glycerol.
Owner:RESDEVCO RES & DEV

Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity

The present invention provides a retroviral vector containing a membrane protein having a hemagglutinin activity. The present inventors constructed a retroviral vector pseudotyped by the membrane protein having a hemagglutinin activity. This viral vector showed gene transfer at a high efficiency into host cells. In particular, it was established that genes can be transferred thereby at a high efficiency into cells into which genes can hardly be transferred by the conventional techniques, for example, blood cells and hematopoietic cells including hematopoietic stem cells, and mucous cells including mucosa epithelial cells. The viral vector of the present invention is highly useful as a vector for gene therapy.
Owner:DNAVEC RES

Gynecological gel for preventing and inhibiting HPV viruses

The invention discloses gynecological gel for preventing and inhibiting HPV viruses. The gynecological gel comprises sodium hyaluronate, extract of bitter bean, extract of argyle leaf, extract of wildchrysanthemum, extract of radix isatidis, extract of Astragalus mongholicus, extract of coptis root, mannitol, Carbomer, triethanolamine and water. The gynecological gel for preventing and inhibitingHPV viruses contains extract of multiple types of plants, does not stimulate the vagina, is safe and has no side effect. The sodium hyaluronate in the gel carries antiviral and antibacterial components which can fast penetrate into the skin and prevents mucous cells from being damaged by viruses. The gynecological gel can fast repair the skin tissue and improve the wound healing and regenerativecapacity. The extract of multiple types of plants in the gel can improve immunity and produce good antiviral effects. The experiment result shows that the gynecological gel has an effective rate of 91.1% to the low-risk HPV infection and an effective rate of 86.1% to the high-risk HPV infection.
Owner:杨平芝

Piglet intestine nutrition regulation and control feed containing cladded zinc oxide

The invention discloses a piglet intestine nutrition regulation and control feed based on cladded zinc oxide. The complete feed comprises 0.06-0.2wt% of cladded zinc oxide and 0.1-0.2wt% of sodium butyrate. The cladded zinc oxide is prepared by performing cladding on ingredients such as stearic acid, long-chain rice bran oil, silicate and carboxymethyl cellulose sodium by use of an inlaid cladding technology, has the effect of effectively preventing zinc oxide from being acidified into zinc ions and consuming hydrogen ions in piglet stomaches and is capable of improving the activity of pepsin, so that the active ingredient (zinc oxide) efficiently enter into an intestinal tract so as to exert effects of resisting bacteria and protecting intestinal mucosa mucoprotein structure; sodium butyrate has an effect of rapidly supplying energy nutrients to piglet intestine mucous cells, and has a food attractant effect on piglets due to unique smell. Cladded zinc oxide and sodium butyrate can achieve a synergetic effect and exert respective effects of protecting the intestinal mucosa mucoprotein structure and promoting mucosa epithelial cell growth, and the effects of improving the feed intake of weanling piglets and obviously reducing the after-weanling diarrhoea rate. The piglet intestine nutrition regulation and control feed is capable of obviously reducing the diarrhoea rate of weanling piglets and improving the feed intake and growth property of the weanling piglets.
Owner:ZHEJIANG UNIV

Traditional Chinese medicine composition capable of treating gastritis, gastric ulcer and duodenal ulcer and preparation method of traditional Chinese medicine composition

The invention discloses a traditional Chinese medicine composition capable of treating gastritis, gastric ulcer and duodenal ulcer and a preparation method of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following components in parts by weight: 7 to 15 parts of caulis dendrobii, 4 to 9 parts of fructus citri sarcodactylis, 5 to 6 parts of rhizoma cyperi, 10 to 15 parts of endothelium corneum gigeriae galli, 4 to 6 parts of Chinese angelica, 4 to 10 parts of herba taraxaci, 3 to 5 parts of bighead atractylodes rhizome, 4 to 6 parts of radix aucklandiae, 3 to 7 parts of fructus aurantii immaturus, 5 to 12 parts of cuttlefish bone, 4 to 6 parts of liquorice root, 5 to 8 parts of rhizoma bletillae, 4 to 9 parts of fructus jujubae and 8 to 12 parts of pheretima. The traditional Chinese medicine composition has a remarkable curative effect on the gastritis, the gastric ulcer and the duodenal ulcer and the healing effect is obvious and is better than various treatment methods and medicines at present; the traditional Chinese medicine composition is high in safety and has no toxic side effect; the medicine can be used for adjusting chief cells, parietal cells and mucous cells and the cells are maintained in a normal level range and kept balanced; the medicine can be used for treating both principal and secondary aspect of disease; all the drugs are scientifically matched and the mutual coordination effect is sufficiently expressed; the traditional Chinese medicine composition has the effects of converging and engendering flesh, nourishing yin and clearing away heat, enhancing the appetite, treating, nourishing and protecting stomach and has the characteristics of low cost, rapid effect and lasting curative effect.
Owner:雷兴业

Process for producing virus vector containing membrane protein having sialic acid-binding in envelope with the use of gram-positive bacterium origin nueraminidase

The present invention provides methods for producing a viral vector comprising a membrane protein that binds to sialic acid as a component of the envelope, using neuraminidase (NA) derived from Gram-positive bacteria. The methods comprise the steps of culturing cells producing a viral vector in the presence of an NA from Gram-positive bacteria, and recovering the produced virus. The methods of this invention enable the production of high titer virus at high cost performance. Such a viral vector is capable of transferring genes at high efficiency into cells such as blood cells and hematopoietic cells, including hematopoietic stem cells, and mucous cells including mucoepithelial cells, those not amenable to gene transfer by conventional methods, and therefore should be useful as a vector for gene therapy.
Owner:DNAVEC RES

Physical therapy nasal cavity magnetic light source

The invention relates to a magnetooptic source for nasal cavity physical therapy and is auxiliary of magnetooptic nasal through instrument and magnetooptic blood through instrument with high viscidity and lipid. It comprises red / blue bicolor LED tube, ring-type permanent magnet, external casing and connection pedestal. Photomagnetic energy can permeate schneiderian membrane for absorption, relieve inflammatory, decrease swelling, recover function of mucous cell, reduce blood viscosity and blood lipid, activate multiple enzymes to scavenge free radical, and improve local and cerebral blood circulation. It can be be used for the treatment of different kinds of rhinitis, paranasal sinusitis, hyperviscous hyperlipemia and auxiliary treatment of cerebral infarction. It has convenient and simple operation which comprises putting magnetooptic source in nasal cavity, connecting light source wire with micromainframe, and settling treatment time, and pulse continuation mode.
Owner:安经克

Product for preventing and treating novel coronavirus and preparation method thereof

The invention discloses a product for preventing or treating coronavirus, which is characterized by comprising sodium chloride or sea salt. Wherein the virus is a coronavirus and / or an influenza virus, and further, the coronavirus is SARS-CoV-2. Experimental results show that the alkaline nasal irrigation agent of the invention can effectively clean the novel coronavirus on nasal sinus mucous cells, and can inhibit the replication and propagation of the novel coronavirus in the mucous cells; therefore, the alkaline nasal irrigation agent disclosed by the invention provides a new effective andsimple measure and method for preventing and treating the epidemic situation of novel COVID19 and Flu.
Owner:JIANGSU TAIDE PHARMA CO LTD

Product for preventing and treating new coronavirus and preparation method thereof

The invention discloses a product for preventing or treating coronavirus, which is characterized by comprising zinc ions. The virus is a coronavirus and / or an influenza virus, and further, the coronavirus is SARS-CoV-2. An alkaline nasal irrigating agent based on sea salt can effectively clean new coronavirus on nasal sinus mucous cells and inhibit replication and propagation of new coronavirus inmucous cells, and meanwhile, the formula containing zinc (Zn2<+>) has stronger capability of inhibiting replication and propagation of new coronavirus in mucous cells.
Owner:JIANGSU TAIDE PHARMA CO LTD

Fixative composition for cytology, cell fixation method and its applications

The present invention refers to a fixative composition for cytology, comprised by an alcoholic base and toluidine blue, preferably mucous cells, like cells from the oral cavity and cells from exo and endocervix.The present invention also describes a method for cytology fixation, and the application and method of this composition for medical use, namely, in neoplasic detection, preferably, cervix and oral cavity cancers.
Owner:TARGETALENT - UNIPESSOAL LDA

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises herba rhodiolae, threonine, serine, cysteine and cystine. Herba rhodiolae has the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.
Owner:何松庆

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses Ganoderma lucidum, Scrophulariaceae, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Scrophulariaceae have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises rhizoma polygonati, threonine, serine, cysteine and cystine. Rhizoma polygonati has the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.
Owner:何松庆

Compound formula for adjusting surface mucous layer barrier of digestive tract and respiratory tract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses rehmannia glutinosa, threonine, serine, cysteine ​​and cystine as a combined formula. Rehmannia glutinosa has the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises glossy ganoderma, threonine, serine, cysteine and cystine. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.
Owner:何松庆

Compound formula adjusting surface mucous layer barrier of digestion tract and respiration tract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The present invention uses salvia miltiorrhiza, threonine, serine, cysteine, cystine and proline as a combined formula. Salvia miltiorrhiza has the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, cysteine, and proline are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises glossy ganoderma, rhizoma bistortae, threonine, serine, cysteine and cystine. Glossy ganoderma and rhizoma bistortae have the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.
Owner:何松庆

Compound formula for adjusting surface mucous layer barrier of digestive tract and respiratory tract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses ganoderma lucidum, rehmannia glutinosa, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Rehmannia glutinosa have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The present invention uses ganoderma lucidum, coix seed, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and coix seed have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Schiff method for dyeing intestinal mucous cell of yellow-feather quail

The invention discloses a Schiff method for dyeing an intestinal mucous cell of a yellow-feather quail. The method comprises the steps of completing Schiff dye liquor preparation, selecting 1cm tissue samples of middle segments of the duodenum, the jejunum, the ileum, the cecum and the colorectum of the quail, immobilizing the tissue samples into a Bouin liquid and slicing conventional paraffin for washing; dyeing a Schiff dye liquor for 40min and washing for 10min; redyeing by using hematoxylin for 1min and carrying out differentiation and blueing; and finally carrying out washing, dehydration, transparency and mounting, wherein the dyeing result is that a goblet cell is red. The Schiff method is easy to color and stable in coloring effect.
Owner:SICHUAN AGRI UNIV

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The present invention uses pearl ginseng, threonine, serine, cysteine ​​and cystine as a combined formula. Pearl ginseng has the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Compound formula for adjusting surface mucous layer barrier of digestive tract and respiratory tract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The present invention uses ganoderma lucidum, Polygonatum polygonatum, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Polygonatum can enhance the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combined prescription for regulating mucous barrier on surface of digestive tract and respiratory tract

The invention discloses a combined formula for adjusting the mucus layer barriers on the surfaces of digestive ducts and breathing ducts, and belongs to the field of medicines. The invention uses Ganoderma lucidum, Cordyceps sinensis, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Cordyceps sinensis have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine and cysteine ​​are the main components of mucin. The combined formula of the invention provides nutrition, oxygen and raw materials for the generation, renewal, repair and secretion of mucins of mucous cells such as goblet cells of digestive ducts and respiratory ducts and mucous glands; Barrier to prevent antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune responses, terminating inflammation, repairing digestive tract and respiratory tract tissue, and preventing and treating digestive system and respiratory system diseases. Effective combination formula .
Owner:何松庆

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers and belongs to the field of medicine. The combined formulation is prepared from glossy Ganoderma, Radix pseudostellariae, threonine, serine, cysteine and cystine. Glossy Ganoderma and Radix pseudostellariae have efficacy of improving human blood supply and oxygen supply, and threonine, serine and cysteine are main ingredients of mucoprotein. The combined formulation provides nutrient, oxygen and raw materials for generation, updating, restoring and mucoprotein secretion of mucous cells like goblet cells and mucous glands of digestive tracts and respiratory tracts. The combined formulation is effective in building normal human digestive tract and respiratory tract surface mucous layer barriers, stopping antigens from approaching, contacting with, adhering to and entering digestive tract and respiratory tract tissue, blocking abnormal immune response, eliminating inflammation, restoring the digestive tract and respiratory tract tissue and preventing and treating digestive system and respiratory system diseases.
Owner:何松庆

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The present invention uses Ming Codonopsis pilosula, threonine, serine, cysteine ​​and cystine as a combined formula. Ming Codonopsis has the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combination formula for regulating surface mucous layer barriers of digestive tract and respiratory tract

The invention discloses a combination formula for regulating surface mucous layer barriers of the digestive tract and the respiratory tract, and belongs to the field of medicine. The combination formula comprises ganoderma lucidum, American ginseng, threonine, serine, cysteine and cystine. ganoderma lucidum and American ginseng have the effects of enhancing human body blood supply and oxygen supply, and threonine, serine and cysteine serve as main ingredients for composing mucoprotein. The combination formula provides nutrition, oxygen and raw materials for generating, updating and repairing of mucous cells such as goblet cells and mucous glands of the digestive tract and the respiratory tract and mucoprotein secreting. The combination formula is an effective combination formula for constructing the normal surface mucous layer barriers of the digestive tract and the respiratory tract of a human body, preventing antigens from approaching, making contact with, adhering to and entering tissue of the digestive tract and the respiratory tract, blocking abnormal immune responses, terminating inflammations, repairing the tissue of the digestive tract and the respiratory tract and preventing and treating diseases of a digestive system and a respiratory system.
Owner:何松庆

Compound formula for adjusting surface mucous layer barrier of digestive tract and respiratory tract

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses Codonopsis pilosula, threonine, serine, cysteine ​​and cystine as a combined formula. Codonopsis pilosula has the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Combined formulation for regulating digestive tract and respiratory tract surface mucous layer barriers

The invention discloses a combined formula for adjusting the mucus layer barrier on the surface of digestive tracts and respiratory tracts, which belongs to the field of medicines. The invention uses ganoderma lucidum, epimedium, threonine, serine, cysteine ​​and cystine as a combined formula. Ganoderma lucidum and Epimedium have the effect of enhancing the blood supply and oxygen supply of the human body; threonine, serine, and cysteine ​​are the main components of mucin. The combination formula of the present invention provides nutrients, oxygen and raw materials for mucous cells such as goblet cells and mucus glands in digestive tracts and respiratory tracts, and for the generation, renewal, repair and secretion of mucin; Barrier, preventing antigens from approaching, contacting, adhering and entering the digestive tract and respiratory tract tissue, blocking abnormal immune response, terminating inflammation, repairing digestive tract and respiratory tract tissue, effective combination formula for preventing and treating digestive system and respiratory system diseases .
Owner:何松庆

Composition formula for regulating surface mucous layer barriers of digestive tracts and respiratory tracts

The invention belongs to the field of medicines and discloses a composition formula for regulating surface mucous layer barriers of digestive tracts and respiratory tracts. The composition formula is composed of Rhizoma Panax Japonicus, threonine, serine, cysteine and cystine. The Rhizoma Panax Japonicus has an efficacy of improving blood supply and oxygen supply of human bodies; the threonine, the serine and the cysteine are main components of mucoprotein. The composition formula has a function of providing nutrition, oxygen and raw materials for mucoprotein secreting, generating, updating and repairing of mucous glands and mucous cells such as goblet cells of the digestive tracts and the respiratory tracts. The composition formula is effective in establishment of normal surface mucous layer barriers of digestive tracts and respiratory tracts of human bodies, prevention of approach, contact, adhesion and entrance of antigens to tissues of the digestive tracts and the respiratory tracts, inhibition of occurrence of abnormal immune response, termination of inflammation, repair of the tissues of the digestive tracts and the respiratory tracts and prevention and treatment of diseases of digestive systems and respiratory systems.
Owner:何松庆
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products